cancel
Showing results for 
Search instead for 
Did you mean: 
AnalyteGuru_KB3
Scientific Advocate II
Scientific Advocate II
Clinical research applications of proteomics increasingly rely on MS-based approaches. Biomarker discovery, development, verification, validation, and quantification are all accessed using these approaches. Although different data collection modes exist for biomarker assessment, John Koomen, Associate Member and Scientific Director of Proteomics at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida, focuses on the emerging DIA mode int his webinar review Combining Data-Independent Analysis (DIA) for Broad-Scale Phenotyping and Targeted Tandem Mass Spectrometry Quantification of Specific Biomarkers.
Version history
Last update:
‎02-22-2016 05:50 AM
Updated by: